On Monday, CVS Health Corp (NYSE: CVS) was 1.54% up from the session before settling in for the closing price of $56.49. A 52-week range for CVS has been $52.77 – $83.25.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 13.36%. When this article was written, the company’s average yearly earnings per share was at -27.16%. With a float of $1.26 billion, this company’s outstanding shares have now reached $1.29 billion.
Considering the fact that the conglomerate employs 300000 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 14.49%, operating margin of 3.33%, and the pretax margin is 2.66%.
CVS Health Corp (CVS) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward CVS Health Corp stocks. The insider ownership of CVS Health Corp is 0.22%, while institutional ownership is 82.51%. The most recent insider transaction that took place on May 02 ’24, was worth 53,879. In this transaction Director of this company bought 1,000 shares at a rate of $53.88, taking the stock ownership to the 21,630 shares. Before that another transaction happened on May 02 ’24, when Company’s Director bought 9,181 for $54.49, making the entire transaction worth $500,294. This insider now owns 9,356 shares in total.
CVS Health Corp (CVS) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around -27.16% per share during the next fiscal year.
CVS Health Corp (NYSE: CVS) Trading Performance Indicators
You can see what CVS Health Corp (CVS) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 0.66. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.20. Likewise, its price to free cash flow for the trailing twelve months is 13.68.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 5.62, a number that is poised to hit 1.55 in the next quarter and is forecasted to reach 7.17 in one year’s time.
Technical Analysis of CVS Health Corp (CVS)
Compared to the last year’s volume of 11.21 million, its volume of 10.15 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 5.77%. Additionally, its Average True Range was 1.80.
During the past 100 days, CVS Health Corp’s (CVS) raw stochastic average was set at 19.64%, which indicates a significant increase from 10.85% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 32.13% in the past 14 days, which was higher than the 28.30% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $59.82, while its 200-day Moving Average is $64.68. Nevertheless, the first resistance level for the watch stands at $57.90 in the near term. At $58.43, the stock is likely to face the second major resistance level. The third major resistance level sits at $59.15. If the price goes on to break the first support level at $56.65, it is likely to go to the next support level at $55.93. Should the price break the second support level, the third support level stands at $55.40.
CVS Health Corp (NYSE: CVS) Key Stats
There are 1,255,373K outstanding shares of the company, which has a market capitalization of 72.16 billion. As of now, sales total 357,776 M while income totals 8,344 M. Its latest quarter income was 91,234 M while its last quarter net income were 1,770 M.
